PATENT CLAIM ANALYSIS

Application Number: 15873473
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2018-05
Patent Classification: ["424", "489000"]

Abstract:
The present invert on relates to sustained release formulations comprising as active ingredient octreotide or a pharmaceutically-acceptable salt thereof and two or more different polylactide-co-glycolide polymers (PLGAs).

Claim (Index 4):
The sustained release pharmaceutical composition according to  claim 1 , wherein the PLGAs have a lactide:glycolide monomer ratio of 90:10 to 40:60.

Metadata:
- Claim Count in Document: 42.0
- Percentile: 86.0
- Lexical Diversity: 1.03448
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['13472219', '10565401', '13408472', '10564494', '13258808']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6837365108261614
- 35 USC 102 Novelty (BERT): 0.5701533314729766
- Combined Prediction Score: 0.6723781928908429
- Mean Citation Score: 280.17915400000004
- Max Citation Score: 477.6233
- Similarity Product: 322.1803684833526

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test